Skip to main content
. 2016 May 3;3(1):e000093. doi: 10.1136/bmjgast-2016-000093

Figure 1.

Figure 1

Model schematic of competing strategies. *Notes: number of weeks to 1 year. ADA, adalimumab; EOW, every other week; IFX, infliximab; VDZ, vedolizumab.